Lien Vandenberk
Leuven, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma.
Journal: Oncoimmunology
Published: December 09, 2016
Pathogen response-like recruitment and activation of neutrophils by sterile immunogenic dying cells drives neutrophil-mediated residual cell killing.
Journal: Cell death and differentiation
Published: November 14, 2016
Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma.
Journal: Science translational medicine
Published: March 04, 2016
Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines.
Journal: Frontiers in immunology
Published: September 30, 2015
Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death.
Journal: Frontiers in immunology
Published: September 17, 2015
Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma.
Journal: Oncoimmunology
Published: March 16, 2015
Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death.
Journal: International journal of cancer
Published: February 21, 2014
Treg infiltration in glioma: a hurdle for antiglioma immunotherapy.
Journal: Immunotherapy
Published: August 03, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026